Performance of RGEN Repligen | 3.1% in 12m
Compare RGEN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Repligen with its related Sector/Index XLV
Performance Duell RGEN vs XLV
| TimeFrame | RGEN | XLV |
|---|---|---|
| 1 Day | -3.56% | 0.18% |
| 1 Week | -5.66% | -0.20% |
| 1 Month | -13.4% | -4.02% |
| 3 Months | -17.8% | -0.78% |
| 6 Months | 20.5% | 13.56% |
| 12 Months | 3.14% | 6.46% |
| YTD | -11.7% | 1.66% |
| Rel. Perf. 1m | -0.77 | |
| Rel. Perf. 3m | -1.45 | |
| Rel. Perf. 6m | 1.77 | |
| Rel. Perf. 12m | -0.15 |
Is Repligen a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Repligen is currently (May 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 6.72 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RGEN as of May 2024 is 136.56. This means that RGEN is currently overvalued and has a potential downside of -13.77% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RGEN as of May 2024 is 136.56. This means that RGEN is currently overvalued and has a potential downside of -13.77% (Sold with Premium).
Is RGEN a buy, sell or hold?
- Strong Buy: 6
- Buy: 3
- Hold: 3
- Sell: 0
- Strong Sell: 0
Values above 0%: RGEN is performing better - Values below 0%: RGEN is underperforming
Compare RGEN with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.66% | -9.26% | 1.23% | -19.02% |
| US NASDAQ 100 | QQQ | -4.49% | -8.17% | 1.92% | -28.56% |
| US Dow Jones Industrial 30 | DIA | -4.22% | -9.33% | 5.50% | -10.34% |
| German DAX 40 | DBXD | -4.78% | -11.44% | 0.45% | -10.32% |
| UK FTSE 100 | ISFU | -7.15% | -15.33% | 4.73% | -5.54% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -8.49% | -14.01% | 19.05% | 15.80% |
| Hongkong Hang Seng | HSI | -9.72% | -16.51% | 22.01% | 22.39% |
| Japan Nikkei 225 | EXX7 | -4.90% | -7.42% | 5.69% | -15.82% |
| India NIFTY 50 | INDA | -6.43% | -15.23% | -0.30% | -24.56% |
| Brasil Bovespa | EWZ | -6.18% | -11.30% | 15.26% | -14.73% |
RGEN Repligen vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.86% | -8.93% | 0.18% | -29.29% |
| Consumer Discretionary | XLY | -5.85% | -9.06% | 6.67% | -16.99% |
| Consumer Staples | XLP | -4.46% | -12.48% | 8.13% | 3.51% |
| Energy | XLE | -1.34% | -10.20% | 10.25% | -9.98% |
| Financial | XLF | -3.81% | -9.79% | -4.54% | -21.04% |
| Health Care | XLV | -5.46% | -9.42% | 6.90% | -3.32% |
| Industrial | XLI | -4.95% | -10.42% | -3.44% | -19.45% |
| Materials | XLB | -6.51% | -9.58% | 2.15% | -9.79% |
| Real Estate | XLRE | -4.49% | -6.67% | 9.72% | 2.87% |
| Technology | XLK | -3.76% | -6.45% | 3.81% | -26.62% |
| Utilities | XLU | -6.81% | -16.90% | 6.65% | 2.08% |
| Aerospace & Defense | XAR | -7.32% | -11.84% | 2.17% | -16.78% |
| Biotech | XBI | -9.70% | -6.49% | -8.75% | -3.29% |
| Homebuilder | XHB | -5.23% | -6.22% | -18.47% | -42.81% |
| Retail | XRT | -3.95% | -4.29% | -2.13% | -15.25% |
Does Repligen outperform its market, is RGEN a Sector Leader?
No, over the last 12 months Repligen (RGEN) made 3.14%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.46%.
Over the last 3 months RGEN made -17.82%, while XLV made -0.78%.
No, over the last 12 months Repligen (RGEN) made 3.14%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.46%.
Over the last 3 months RGEN made -17.82%, while XLV made -0.78%.
| Period | RGEN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -13.44% | -4.02% | -4.18% |
| 3 Months | -17.82% | -0.78% | 2.60% |
| 12 Months | 3.14% | 6.46% | 22.16% |